Vancouver, British Columbia—Although a restrictive transfusion strategy significantly reduces the risk for 30-day all-cause mortality in critical care patients, its benefits are less clear in perioperative patients, according to a meta-analysis by a Canadian research team.
“Although packed red blood cells are arguably the best therapy to use when you have a problem with oxygen-carrying capacity, they come with a couple risks, such as the potential for transfusion reactions and